Ratings by Leerink
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 10/20/2026 | Andrew Berens | Kazia Therapeutics | KZIA | New Coverage | Outperform (N/A) |
30.00 (N/A) |
7.85 (7.91) |
0.76% | Details |
| 10/12/2026 | Will Soghikian | Equillium | EQ | New Coverage | Outperform (N/A) |
6.00 (N/A) |
1.41 (1.30) |
-7.8% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 4,185 more... | |||||||||
